Ultraviolet Germicidal Irradiation Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Ultraviolet Germicidal Irradiation market is Segmented by Type, End User (Hospitals and Surgical Centers, Research Laboratories, Other End Users), and Geography.

Ultraviolet Germicidal Irradiation Market Snapshot

Ultraviolet Germicidal Irradiation Market Snapshot
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 8.9 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Ultraviolet Germicidal Irradiation Market Market Overview

Ultraviolet germicidal irradiation (UVGI) is a disinfection method that, in medical practice, is used in cleaning hospital rooms, operation theaters, and research facilities and laboratories.

Hospital Acquired Infections (HAI) are very prevalent globally, including developed countries. In the survey, published in the New England Journal of Medicine in 2014, conducted in 183 US hospitals with nearly 4% of the patients had HAI. Even European hospitals suffer this from HAI. This has led to an increase in demand for technologies that can eliminate the germs and pathogens effectively. As a result, UVGI technologies have undergone technological advancements in recent years. These factors have hence helped the UVGI market growth.

However, the cost of installation and maintenance of UVGI disinfectants is high. Hence, hospitals with limited resources and budgets are unable to benefit from this technology. This has also hindered the growth of the ultraviolet germicidal irradiation market.

Scope of the Report

Ultraviolet germicidal irradiation (UVGI) lamps and systems are a disinfection method. They use short-wavelength ultraviolet light to kill or inactivate microorganisms by destroying nucleic acids and disrupting their DNA, leaving them unable to perform vital cellular functions.

In the report, a detailed analysis of the ultraviolet germicidal irradiation market is provided. The market is evaluated by collating revenues generated across segments, categorized by type, end user, and geography.

By Type
Air Disinfectant
Surface Disinfectant
Other Types
By End User
Hospitals and Surgical Centers
Research Laboratories
Other End Users
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

The Usage in Hospitals and Surgical Centers is expected to Dominate the Market

Hospital-acquired Infections (HAI) are highly prevalent in hospitals and surgical centers. According to the Journal of clinical infectious disease, 2017, out of the 5,415 patients surveyed in the hospitals of Singapore, 646 patients, accounting for 11.9%, had 727 distinct HAIs. The burden of HAIs in more developed regions, like Europe, is enormous too. A report published in the Public Library of Science (PLOS) Medicine journal, in 2016, estimated that 2,609,911 new cases of HAI occur every year in the European Union and European Economic Area (EU/EEA). Moreover, the incidence of HAI increases with age. As the global geriatric population is rising (the United Nations report, World Population Aging 2017), the frequency of HAI is also expected to increase.

Continuous protection from ultraviolet germicidal irradiation technologies can reduce airborne bacteria, which can help lower the number of HAIs, including those caused by contact pathogens. Reduced infections result in lessened morbidity and lower costs for both the and the patient. As a result of these benefits, the demand for UVGI instruments has increased, which is expected to help the growth of the ultraviolet germicidal irradiation market.

Graph - 1

North America is Expected to Dominate the Market

In North America, the rate of hospital-acquired infection (HAI) is high and is understated as per many researchers. In Canada, there are rising cases of hospital-acquired infections. According to the estimates of the Canadian Nosocomial Infection Surveillance Program (CNISP), 1 in 217 patients acquired an infection while in hospital in 2017. According to a 2017 report by Hospital CMQ, in Mexico, the rate of HAIs in hospitals is between 2.1% and 15.8%.

However, North American countries of the United States (US) and Canada have a developed and well-structured health care system. These systems also encourage research and development. These policies encourage global players to enter the United States and Canada. As a result, these countries enjoy the presence of many global market players. As high demand is met by the presence of global players in the region, the market is further expected to increase.

Graph - 2

Competitive Landscape

The global key players are manufacturing the majority of the ultraviolet germicidal irradiation instruments. Market leaders with more funds for research and a better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing the emergence of some small players due to the rise of awareness. This has also helped the ultraviolet germicidal irradiation market grow.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Hospital-acquired Infection

      2. 4.2.2 Technological Advancements in Ultraviolet Germicidal Irradiation

    3. 4.3 Market Restraints

      1. 4.3.1 Limitations Associated with Ultraviolet Germicidal Irradiation (UVGI)

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Type

      1. 5.1.1 Air Disinfectant

      2. 5.1.2 Surface Disinfectant

      3. 5.1.3 Other Types

    2. 5.2 By End User

      1. 5.2.1 Hospitals and Surgical Centers

      2. 5.2.2 Research Laboratories

      3. 5.2.3 Other End Users

    3. 5.3 Geography

      1. 5.3.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.3.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 American Ultraviolet

      2. 6.1.2 Angioscore Ltd

      3. 6.1.3 Aquionics

      4. 6.1.4 Atlantic Ultraviolet Corporation

      5. 6.1.5 Ensavior


      7. 6.1.7 Koninklijke Philips NV

      8. 6.1.8 UltraViolet Devices

      9. 6.1.9 Volcano Corporation

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Ultraviolet Germicidal Irradiation Market market is studied from 2018 - 2026.

The Ultraviolet Germicidal Irradiation Market is growing at a CAGR of 8.9% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

American Ultraviolet, Atlantic Ultraviolet Corporation, Aquionics, Ensavior, Koninklijke Philips N.V. are the major companies operating in Ultraviolet Germicidal Irradiation Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!